132 related articles for article (PubMed ID: 33130293)
1. Synthesis and evaluation of HIF-1α inhibitory activities of novel panaxadiol derivatives.
Wang DY; Li YW; Zhang LH; Lv LY; Zhao YQ; Jin XJ; Piao HR
Bioorg Med Chem Lett; 2020 Dec; 30(24):127652. PubMed ID: 33130293
[TBL] [Abstract][Full Text] [Related]
2. Panaxadiol inhibits programmed cell death-ligand 1 expression and tumour proliferation via hypoxia-inducible factor (HIF)-1α and STAT3 in human colon cancer cells.
Wang Z; Li MY; Zhang ZH; Zuo HX; Wang JY; Xing Y; Ri M; Jin HL; Jin CH; Xu GH; Piao LX; Jiang CG; Ma J; Jin X
Pharmacol Res; 2020 May; 155():104727. PubMed ID: 32113874
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Cytotoxicity Evaluation of Panaxadiol Derivatives.
Xiao S; Lin Z; Wang X; Lu J; Zhao Y
Chem Biodivers; 2020 Jan; 17(1):e1900516. PubMed ID: 31725193
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-tumor evaluation of panaxadiol derivatives.
Liu XK; Ye BJ; Wu Y; Lin ZH; Zhao YQ; Piao HR
Eur J Med Chem; 2011 Jun; 46(6):1997-2002. PubMed ID: 21439693
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and evaluation of novel ursolic acid derivatives as HIF-1α inhibitors with anticancer potential.
Chi KQ; Wei ZY; Wang KS; Wu J; Chen WQ; Jin XJ; Piao HR
Bioorg Chem; 2017 Dec; 75():157-169. PubMed ID: 28950243
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of the HIF-1α inhibitory activities of novel ursolic acid tetrazole derivatives.
Zhang LH; Zhang ZH; Li MY; Wei ZY; Jin XJ; Piao HR
Bioorg Med Chem Lett; 2019 Jun; 29(12):1440-1445. PubMed ID: 31006525
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1α pathway.
Shang FF; Wang JY; Xu Q; Deng H; Guo HY; Jin X; Li X; Shen QK; Quan ZS
Eur J Med Chem; 2021 Aug; 220():113474. PubMed ID: 33930802
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and screening of novel ursolic acid derivatives as potential anti-cancer agents that target the HIF-1α pathway.
Wu J; Zhang ZH; Zhang LH; Jin XJ; Ma J; Piao HR
Bioorg Med Chem Lett; 2019 Mar; 29(6):853-858. PubMed ID: 30728113
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-tumor evaluation of panaxadiol halogen-derivatives.
Xiao S; Chen S; Sun Y; Zhou W; Piao H; Zhao Y
Bioorg Med Chem Lett; 2017 Sep; 27(17):4204-4211. PubMed ID: 28757064
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 3-(phenylethynyl)-1,1'-biphenyl-2-carboxylate derivatives as new HIF-1 inhibitors.
Wang S; Wang X; Shao Y; Shao K; Wang Y; Guo X; Dong H; Zhao W; Li Y; Li G
Bioorg Chem; 2021 Nov; 116():105298. PubMed ID: 34454298
[TBL] [Abstract][Full Text] [Related]
11. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha.
Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC
Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007
[TBL] [Abstract][Full Text] [Related]
12. Novel HIF-1α inhibitor CDMP-TQZ for cancer therapy.
Chu PC; Wu YC; Chen CY; Hung YS; Chang CS
Future Med Chem; 2021 Jun; 13(12):1057-1072. PubMed ID: 33896195
[No Abstract] [Full Text] [Related]
13. Total synthesis and biological evaluation of 7-hydroxyneolamellarin A as hypoxia-inducible factor-1α inhibitor for cancer therapy.
Li G; Shao Y; Pan Y; Li Y; Wang Y; Wang L; Wang X; Shao K; Wang S; Liu N; Zhang J; Zhao W; Nakamura H
Bioorg Med Chem Lett; 2021 Oct; 50():128338. PubMed ID: 34469710
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 1,2-dithiol-3-thiones and pyrrolo[1,2-a]pyrazines as novel hypoxia inducible factor-1 (HIF-1) inhibitor.
Lee YH; Lee JM; Kim SG; Lee YS
Bioorg Med Chem; 2016 Jun; 24(12):2843-51. PubMed ID: 27157007
[TBL] [Abstract][Full Text] [Related]
15. Dictamnine promotes apoptosis and inhibits epithelial-mesenchymal transition, migration, invasion and proliferation by downregulating the HIF-1α and Slug signaling pathways.
Wang JY; Wang Z; Li MY; Zhang Z; Mi C; Zuo HX; Xing Y; Wu YL; Lian LH; Xu GH; Piao LX; Ma J; Jin X
Chem Biol Interact; 2018 Dec; 296():134-144. PubMed ID: 30266538
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of benzofuran derivatives as novel anti-pancreatic carcinoma agents via interfering the hypoxia environment by targeting HIF-1α pathway.
Xu XL; Yang YR; Mo XF; Wei JL; Zhang XJ; You QD
Eur J Med Chem; 2017 Sep; 137():45-62. PubMed ID: 28554092
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of biarylquinoline derivatives as novel HIF-1α inhibitors.
Wu YC; Lu MT; Lin TH; Chu PC; Chang CS
Bioorg Chem; 2022 Apr; 121():105681. PubMed ID: 35176558
[TBL] [Abstract][Full Text] [Related]
18. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
19. Ring-truncated deguelin derivatives as potent Hypoxia Inducible Factor-1α (HIF-1α) inhibitors.
Kim HS; Hong M; Lee SC; Lee HY; Suh YG; Oh DC; Seo JH; Choi H; Kim JY; Kim KW; Kim JH; Kim J; Kim YM; Park SJ; Park HJ; Lee J
Eur J Med Chem; 2015 Nov; 104():157-64. PubMed ID: 26457742
[TBL] [Abstract][Full Text] [Related]
20. Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis.
Paradziej-Łukowicz J; Skwarska A; Peszyńska-Sularz G; Brillowska-Dąbrowska A; Konopa J
Cancer Biol Ther; 2011 Oct; 12(7):586-97. PubMed ID: 21775820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
